LSL Pharma Group Inc. (TSXV:LSL)
0.3600
+0.0200 (5.88%)
At close: Dec 19, 2025
-10.00% (1Y)
| Market Cap | 43.64M |
| Revenue (ttm) | 26.80M |
| Net Income (ttm) | 2.78M |
| Shares Out | 121.22M |
| EPS (ttm) | 0.02 |
| PE Ratio | 15.87 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 146,500 |
| Average Volume | 74,895 |
| Open | 0.3450 |
| Previous Close | 0.3400 |
| Day's Range | 0.3450 - 0.4100 |
| 52-Week Range | 0.2900 - 0.5300 |
| Beta | -0.23 |
| RSI | 49.28 |
| Earnings Date | Nov 25, 2025 |